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Abstract.  Dystrophin,  the protein product of the 
Ducherme muscular dystrophy locus, is a protein of 
the membrane cytoskeleton that associates with a 
complex of integral and membrane-associated proteins. 
Of these, the 58-kD intracellular membrane-associated 
protein,  syntrophin,  was recently shown to consist of a 
family of three related but distinct genes. We ex- 
pressed the eDNA of human Brsyntrophin and the 
COOH terminus  of human dystrophin in reticulocyte 
lysates using an in vitro transcription/translation  sys- 
tem.  Using antibodies to dystrophin we immunopre- 
cipitated these two interacting proteins in a variety of 
salt and detergent conditions.  We demonstrate that the 
53 amino acids encoded on exon 74 of dystrophin,  an 
alternatively spliced exon, are necessary and sufficient 
for interaction with translated fll-syntrophin in our as- 
say. On the basis of its alternative  splicing,  dystrophin 
may thus be present in two functionally distinct popu- 
lations.  In this recombinant expression system, the 
dystrophin relatives, human dystrophin related protein 
(DRP or utrophin) and the 87K postsynaptic protein 
from Torpedo electric organ,  also bind to translated 
Bz-syntrophin.  We have found a COOH-terminal 37-kD 
fragment of Bi-syntrophin sufficient to interact with 
translated dystrophin and its homologues,  suggesting 
that the dystrophin binding site on flrsyntrophin oc- 
curs on a region that is conserved among the three 
syntrophin homologues. 
UCH~NNE muscular dystrophy and the allelic disease 
Becker muscular dystrophy are due to defects of the 
dystrophin  gene  (Emery,  1993).  Dystrophin  is  a 
membrane-associated protein found throughout  the muscle 
sarcolemma, as well as in the postsynaptic density of a subset 
of neurons (Arahata et al.,  1988; Lidov et al.,  1990, 1993; 
Byers et al.,  1991). The shorter dystrophin  products of 116 
and 71 kD, Dpll6 and DpT1 are,  respectively,  found in the 
outer membrane of Schwann cells and in many different tis- 
sues (Lederfein et al., 1992; Byers et al., 1993). In skeletal 
muscle dystrophin is presumed to participate  in maintaining 
the stability of the membrane during  the repeated cycles of 
contraction  and relaxation of the muscle fiber. By establish- 
ing the functional domains and biochemical organization  of 
dystrophin  with other components of the membrane cyto- 
skeleton, we hope to better understand  its role. 
The autosomal relative  of dystrophin,  dystrophin-related 
protein (DRP~ or utrophin),  is expressed in many cell types 
other than muscle (Love et al.,  1989, 1991; Tinsley et al., 
1992).  In muscle,  DRP localizes  in the upper folds of the 
neuromuscular junction and at the myotendinous  junction 
(Khurana  et al.,  1991; Ohlendieck et al.,  1991; Cartaud et 
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assay;  TMV,  tobacco mosaic virus. 
al., 1992). Another dystrophin relative,  the 87K postsynap- 
tic protein of Torpedo (Carr et al., 1989), also has homology 
to the COOH terminus  of dystrophin  and copurifies  with 
dystrophin and syntrophin from electric organ extracts (Wag- 
ner et al.,  1993).  Proteins immunologically  related to the 
87K protein have also been identified in rat myotubes (Carr 
et  al.,  1989)  and  a  wide  variety  of  other  rat  tissues 
(Kramarcy et al., 1994). The three genes coding for dystro- 
phin,  DRP,  and the 87K protein,  form the closest known 
members of the dystrophin  family. 
Dystmphin can be isolated  from rabbit skeletal  muscle 
microsomes by affinity chromatography  to wheat germ ag- 
glutinin (Campbell and Kahl, 1989). The complex of integral 
and peripheral membrane proteins that copurify with dystro- 
phin has come to be known as the dystrophin  glycoprotein 
complex (DGC)  (Yoshida and  Ozawa,  1990;  Ervasti  and 
Campbell,  1991). The DGC also copurifies  with the more 
widely expressed DRP (Matsumura et al.,  1992). 
The  syntrophins  copurify with  the  DG-C (Yoshida and 
Ozawa,  1990; Ervasti and Campbell,  1991) and are a bio- 
chemically  heterogeneous  group  of  58-kD  intracellular 
membrane-associated  proteins  (Yamamoto  et  al.,  1993). 
These proteins are encoded by a family  of three separate 
genes  with distinct  patterns  of expression  (Adams  et al., 
1993; Ahn et al.,  1994; Yang et al.,  1994) and distribution 
throughout  the muscle membrane (Peters et al., 1994). The 
relatively  acidic  ct-syntrophin  (also  known  as mouse syn- 
trophin-1, rabbit 59-DAP, and Torpedo syntrophin)  is most 
abundant in muscle (Adams et al., 1993; Yang et al., 1994). 
© The Rockefeller University Press, 0021-9525/95/02/363/9  $2.00 
The Journal of Cell Biology, Volume 128, Number 3, February 1995 363-371  363 Of the  two  basic  isoforms,  fll-syntrophin  is  expressed  in 
liver, pancreas, kidney, skeletal muscle, lung, placenta, and 
in lower levels in brain and heart (Alan et al.,  1994).  The 
B2-syntrophin (previously identified as mouse syntrophin-2) 
is present in low levels in many tissues (Adams et al., 1993). 
Subcellular  localization  with  isoform-specific  antibodies 
shows that tx-syntrophin is expressed throughout the entire 
muscle  membrane.  On  the  other  hand,  B2-syntrophin  is 
found only at the postsynaptic densities of the muscle mem- 
brane  (Peters  et  al.,  1994).  The  cellular  localization  of 
/~l-syntrophin is yet to be shown. 
Syntrophin purified  from the  electric  organ of Torpedo 
(Froehner et al.,  1987) interacts directly with dystrophin in 
immuno-affinity and blot-overlay experiments (Buffer et al., 
1992;  Cartand  et al.,  1993).  Quantitative  immunoabsorp- 
tion of dystrophin followed by immuno-absorption of syntro- 
phin from Torpedo electroplaque extract showed that there 
is  a  distinct  non-dystrophin-associated pool of syntrophin 
that contains the 87K protein (Buffer et al., 1992). A similar 
imrnuno-aflinity purification of syntrophin from several rat 
tissues  shows  that  dystrophin,  Dp71  isoforms,  DRP,  and 
87K-like proteins all copurify with syntrophin (Kramarcy et 
al.,  1994).  The syntrophin binding site on dystrophin has 
been localized to the COOH-terminus of dystrophin (Suzuki 
et al.,  1992,  1994). 
The widespread distribution of the syntrophins and their 
coincident expression with Dp71 and DRP in non-muscle tis- 
sues suggests that these proteins may play an analogous role 
to dystrophin in the membrane cytoskeleton of these other 
cell types  (Kramarcy et al.,  1994).  It is possible  that the 
specific subeellular  localization of the syntrophin isoforms 
accounts for the specificity of localization and function of 
dystrophin,  Dp71,  and DRP. 
The observation that anti-87K protein or anti-syntrophin 
antibodies copurify 87K, dystrophin, and syntrophin led to 
the proposal that an arnphipathic repeated heptad motif on 
both dystrophin and 87K could be the basis for their associa- 
tion (Wagner et al.,  1993).  This proposal does not exclude 
the possibility of a distinct syntrophin binding site on both 
dystrophin and the 87K protein,  which is supported by the 
copurification  of  87K  with  syntrophin  in  a  dystrophin- 
depleted extract (Buffer et al.,  1992). 
To  more  fully  understand  these  relationships,  ~ve have 
used recombinant techniques to study the syntrophin-dys- 
trophin interaction by using an in vitro expression system. 
We have expressed portions of the human dystrophin gene 
and have mapped its site of interaction with a defined isoform 
of human syntrophin,  Bt-syntrophin,  by coimmunoprecipi- 
ration. In our assay, the 53 amino acids encoded on exon 74 
of dystrophin are sufficient to bind to in vitro-translated 131- 
syntrophin.  In the accompanying paper,  Suzuki et al.  have 
independently obtained a similar localization of this binding 
site by using a blot-overlay approach (Suzuki et al.,  1995). 
We have also expressed a naturally occurring spliced iso- 
form of dystrophin, in which 110 amino acids (including the 
53 amino acids of exon 74) are internally deleted from the 
COOH terminus  of dystrophin,  and this  isoform does not 
bind/51-syntrophin in our assay. This characterization of the 
syntrophin binding site on dystrophin suggests that,  on the 
basis of its alternative splicing, dystrophin is present in two 
functionally distinct populations. In addition, we have found 
in our in vitro assay that the dystrophin relatives DRP and 
the 87K postsynaptic protein also interact with syntrophin, 
demonstrating that this binding site on dystrophin is func- 
tionally  conserved.  The  finding  that  syntrophin binds  the 
three dystrophin family members suggests that they may play 
functionally analogous roles. 
Materials and Methods 
Construction of  a Vector  for Transcription 
and Translation 
To facilitate efficient and processive translation of cDNAs, an expression 
cassette was designed and constructed from synthetic oligonucleotides  by 
pbosphoramidite synthetic chemistry (Applied Biosystems Inc.,  Foster 
City, CA). A series of  partial, overlapping, and complementary  oligunucle- 
otides with BssHII complementary ends were ligated to the  plasmid 
Bluescript II KS+ (Stratagene Inc., CA), in which the RNA polymerase 
and multiple cloning  site was removed  by digestion with BssHlI. The result- 
ing expression vector, pMGT, contains the following features (Fig. 1 a): a 
T7 RNA polymerase late promoter (Panayotatos  and Wells, 1979); the 5' 
untranslated region (fl') of the tobacco mosaic virus (TMV) (Gailie et al., 
1987, 1988); an initiator ATG codon  in the context of a Kozak consensus 
(M) (Kozak, 1986); an extensive  polylinker (MCS); stop codons  in all three 
reading frames; a short poly(A)  + region; a polyadenylatiun signal; and 
other unique restriction sites for linearization of the plasmid (L). 
The expression vector pMGT was further modified to accommodate  an 
EcoRI fragment in another reading frame (Table I). This modified  vector, 
TR-3, was used to produce the expression construct TDR (see below). To 
express the octapeptide FLAG  antigen 0BI) at the NH2 terminus of  the ex- 
pressed polypeptide, complementary  oligonucleotides  (Table I) were ligated 
to the NcoI/BamHI  site on pMGT. The resulting vector, pFHR, permitted 
the introduction of inserts as BamHI/EcoRI fragments, and the transla- 
tion of a fusion polypeptide with the sequence beginning MDYKDDDD 
KGS... (Table 1). 
Subcloning of  cDNA's into Expression Vector 
PCR primers were synthesized  to amplify regions of specific cDNAs. The 
oligonucleotides used in the subcloning of dystrophin and all other con- 
structs used in this report are listed in Table I (Sambrook  et al., 1989). For 
dystrophin, 100 ng of plasmid p9-14, encoding  the entire COOH terminus 
of dystrophin (Koenig et ai.,  1987), was used as template with 100 pmol 
of each primer. To maintain the fidelity of  the amplified DNA, we used the 
thermo-stable DNA polymerase Vent polymerase (New England Biolabs, 
Sharon, MA) in all amplifications. Amplified  DNA was cloned into pMGT 
using restriction enzymes indicated (Table I). To confirm the accuracy of 
the amplification and cloning steps, partial sequence was obtained by the 
dideoxy-terminator method using Taq polymerase  and analyzed  on an Ap- 
plied Biosystems automated sequencer. 
Because the COOH terminus of dystrophin has numerous NcoI sites, 
some constructs were produced by partial digestion with NcoI and XhoI, 
isolated by electrophoresis, and then ligated into the expression vector. In 
other cases, the inserts were cloned into the KpnI to SpeI site of pMGT, 
resulting in a fusion protein that contains the additional amino acids MGT 
•  .  .  at the NH2  terminus of the native sequence. To introduce the seven 
unique amino acids at the NH: terminus of Dp71, a two-step amplification 
was used. The oligonucleotide  F1 was used in the first round to amplify 
cDNA from exon 63 and then F2 in the second round to add the novel se- 
quence (Table I). 
To construct Dp71All0, a naturally occurring splice variant of Dp71 
missing exons 71 through  74 was isolated from a human fetal brain cDNA 
library. We isolated the SacI restriction fragment which spans the alterna- 
tively spliced exons 71-74 and replaced the SacI fragment in the expression 
plasmid encoding Dp71. 
The cDNA clone to the COOH terminus of human DRP containing the 
region homologous  to the entire COOH terminus of  dystrophin, DRP2, was 
kindly provided by T. S. Khurana (in our laboratory). This EcoRI-flanked 
clone begins at nucleotide 8257 of  the DRP cDNA  encoding  the amino acids 
(2753-3432) starting with NDLSSQLSP... (Tmsley  et al., 1992). We sub- 
cloned this EcoRI fragment  of  DP,  P2 into a modification  of  pMGT, in which 
the EcoRI reading frame was modified  to accommodate  the reading frame 
(TR-3, Table I). The insert within expression plasmid FDR, coding for the 
region of DRP that is homologous  to exon 74 of dystrophin; was PCR- 
amplified from this same DRP cDNA. 
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Clone name  Forward and reverse oligonucleotides*  Expressed protein sequence* 
C2979 
C3145 
13971 
Dp71A148 
Dp71A276 
C3356A148 
Dp71All0 
pFHR 
F72-74 
F73-74 
F74 
F74-01 
F74A 
F74B (F74-32) 
FB1S 
FDR 
F87 
T87 
TR3 
TDR 
ACT TCC ACC ATG GCA CTG CGA GGA GAA ATT 
GTG GAG TCG ACT TCC TAC ATT GTG TCC  TCT CTC ATT GGC T 
NcoI partial digestion product of C2979 
FI:  AGG GAA CAG CTC AAA GG-C CAC GAG ACT CAP, ACA ACT 
F2: ATG GGT ACC ATG AGG GAA CAG CTC AAA GGC 
R: TCA CTA GTT GTA AAA CAT TTA TTC TGC TCC 
FI and F2 
GAC ACT AGT CAG GAC AGG CCT TTA TGT TCG 
Fl  and F2 
GAT ACT AGT TCA GGG AGT TTC CAT GTT GTC 
Dp71  A148 digested with NcoI and recircularized 
replaced the internal Sad fragment from Dp 71 with that of 19A5 
C  ATG GAC TAC AAG GAC GAC GAC GAC AAG G 
GA TCC  CTT GTC GTC GTC GTC CTT GTA GTC 
GTA GGA TCC GCG CCT GCC TCG TCC CCT 
G-G GGA ATT CTA TTT ATG TTC GTG CTG CTG 
TAT GGA TCC AGG CTA GCA GAb, ATG GAA 
GG GGA ATT CTA TTT ATG TIC GTG CTG CTG 
AAT GGA TCC ATA GAT GAT GAA CAT TTG 
GG GGA ATT CTA TTT ATG TTC GTG CTG CTG 
AAT GGA TCC ATA GAT GAT GAA CAT TTG 
CTG GAA TCC AAT TCC TGT TTT CTT CCT CAA 
F74 digested with BglII and re-circularized 
AAG GGA TCC TTA GAG AGT GAG GAA AGA GG 
GG GGA ATT CTA TTT ATG TTC GTG CTG CTG 
~A1 digested with BamHI and EcoRI and ligated into FHR 
ACA GGA TCC GTG GAA GAC GAG CAC GC 
CAT GAA TTC ACT GTA GAT TTC TTT GTT C 
AGT GGA TCC AGA ATG GAT GAA GAA C 
TCT GAA TTC ACT GCA GGA ~  CTC TAT 
C  ATG GTG AAA ACT GCA NcoI to PstI linker 
GT TTT CAC 
C  ATG GGA ATG NcoI to EcoRI linker 
A  ATT CAT TCC 
Eco RI fragment of DRP-2 cloned into TR3 
M  (dystrophin 2980-3685) 
dystrophin 3145-3685 
MGTMREQLKG (dys 3076-3685) 
MGTMREQLKG (dys 3076-3537) 
MGTMREQLKG (dys 3076-3409) 
dystrophin 3356-3537 
M  DYKDDDDK  GS 
MDYKDDDDKGS  (dys 3421-3534) 
MDYKDDDDKGS  (dys 3443-3534) 
MDYKDDDDKGS  (dys~465-3534) 
MDYKDDDDKGS  (dys 3465-3519) 
MDYKDDDDKGS  (dys 3465-3496) N 
MDYKDDDDKGS  (dys 3498-3534) 
MDYKDDDDKGS  (131 syntro 205-537) 
MDYKDDDDKGSVEDEH  .  .  . 
MDYKDDDDKGSRMDEE  .  .  . 
native 87K sequence 
MGML .  .  . 
MGML (DRP 2753-3432) 
* Oligonaeleotides are written in the conventional 5' to 3' direction. In cases where PCR products were not used to generate the construct, the cloning strategy 
is briefly described. 
~: Single 1~  amino acid symbols are used. Amino acid numbers for human dystrophin, human flt-syntrophin, human DR.P, and Torpedo 87K protein are respec- 
tively from Koenig et al.,  1988; Aim et al.,  1994; Tinsley et al.,  1993; and Wagner et al.,  1993. 
In the expression of Bi-syntrophin, the eDNA  clone #AI  was  used 
directly from within the Bluescript vector (Alan et al., 1994). This plasmid 
expressed protein at much lower levels  than the expression vectors de- 
scribed above. To construct FjSIS, the BamI-II/ECORI fragment of the plas- 
mid BAI was subeloned into pFHR, so that the last 335 of the 537 amino 
acids of Bl-syntrophin were expressed  as a fusion protein with the FLAG 
antigen. 
The entire Torpedo 87K protein eDNA was kindly provided by J. B. Co- 
hen (Wagner et al.,  1993).  The eDNA was subcloned into the NcoI to 
EcoRI site within pMGT1 in three parts: (a) an oligonucleotide  linker cod- 
ing for the first five amino acids of the 87K protein (see Table I); (b) the 
PstI to BamHI fragment (nucleotides  128-345); and (c)  the BamHI to 
EcoRI fragment (nncleotides  346-2594) from the 87K eDNA. The insert 
within expression plasmid F87, coding for the region of 87K that is homolo- 
gous to exon 74 of dystrophin, was PCR-amplified  from this 87K eDNA 
(Table I). 
Transcription  and Translation of cDNA Sequences 
The polypeptides of interest were produced from plasmid DNA in the TNT 
T7 coupled reticulocyte  lysate system (Promega Corp., Madison, WI) in a 
reaction volume of 50/~1 as per the manufacturer's protocol. When indi- 
cated, the reaction was carried out in a reaction buffer in which 0.2 ~Ci (4 
t~l) of L-[U-t4C]leucine  (>300 mCi/mmol; Amersham Corp., Arlington 
Heights,  IT,) was  added to a  50-pl reaction mix that lacked leucine.  In 
general, the protein which is recognized by the antibody (cognate protein) 
was expressed  without the incorporation of radioactivity,  and the protein 
which did not interact with the antibody (probe protein) was separately  ex- 
pressed with [14C]leucine (as above).  In some cases the cognate protein 
(which binds the antibody) was synthesized  with 0.05 pCi of [14C]leucine 
added to the synthesis reaction so that the presence of the polypeptide could 
be followed through the immnnoprecipitation and SDS-PAGE. 
Polypeptide secondary structure predictions were made with the Univer- 
sity  of  Wisconsin GCG  Sequence  Analysis  Software  Package  (Madi- 
son, WI). 
Immunopredpitation. Protein interactions were assayed by their copre- 
cipitation in the following  assay. Directly  from the translation reaction 
above,  10 t~l of both cognate and probe proteins were incubated together 
with 20 ~1 of 10 mM Tris-buffered saline (pH 8), 0.1% Tween-20 (TBST). 
After 2-h incubation at room temperature,  10 td of unpurified immune se- 
rum raised against the COOH terminus of dystrophin (dl 1) (Koenig and 
Kunkel,  1990) or 1 #1 of anti-FLAG monoclonal antibody (M2; IBI/Kodak, 
Ahn and Kunkel Syntrophin Binds a Spliced Exon of Dystrophin  365 New Haven, CT) were added with 20 ~l of TBST. After 2-h incubation at 
room temperature,  30 ~1 of a 50% suspension of protein A-agarose or pro- 
tein G-Sepbarose (Sigma Chem Co., St. Louis,  MO) were added and in- 
cubated for 30 rain. The beads were pelleted at 10000 g for 1 rain at room 
temperature and the supernatant removed.  The beads were washed with 3 
×  1 ml TBST (or TBST with 0, 150, 1,000 mM NaCI; TBST with 1% Triton 
X-100; radioimmune precipitation assay (RIPA) wash buffer is TBST with 
1% Triton X-100, 1% sodium deoxycholate and 0.1% SDS) and pelleted. Af- 
ter adding 25/~1 of 2× loading buffer (Byers et al., 1991) to the pellet, the 
sample  was boiled for 3 rain and then stored at  -200C. 
SDS-PAGE and Autoradiography.  All samples were analyzed by elec- 
trophoresis on denaturing discontinuous  buffer systems in 10%, 4-15%, or 
4--20% acrylamide gradients (Laemmli,  1970).  14C-methylated high mo- 
lecuiar weight standards (10-50/LCi/rng) were from Amersham Corp. Gels 
were fixed in 10% methanol/10% acetic acid, stained with Coomassie Bril- 
liant Blue to confirm the recovery  of antibody,  destuined  in fix buffer, 
washed in water, dried onto cellulose,  and exposed to a storage phosphor 
plate for four days. The plate was scanned by a PhosphorImnger (Molecular 
Dynamics,  Sunnyvale, CA) and analyzed with ImngeQuant software (Mo- 
lecular Dynamics).  The positive band activities of 50-8,000 units per pixel, 
depending on the probe, were easily discernible over the background pixel 
value of 1-15. The image was converted to an eight bit TIFF file, processed 
on Adobe Pbotoshop to adjust contrast and scale light levels, and labeled 
in Aldus  SuperPaint. 
Results 
Expression of  Dystrophin and Syntrophin In Vitro 
The expression vector pMGT (Fig. 1 a) directs the high level 
synthesis of a variety of stable, soluble polypeptides in an in 
vitro transcription/translation system. These expressed pro- 
teins are  synthesized in the presence of [~4C]leucine and 
analyzed by denaturing polyacrylamide gel electrophoresis 
and autoradiography (Fig. 1 b). The eDNA translated from 
pMGT incorporates  10-1,000  times more label than from 
similar eDNA in the Bluescript polylinker (Fig. 1 b, lane 8 
is from Bluescript).  Presumably due to a favorable 5' un- 
translated region and a  strong initiator of translation (see 
Materials and Methods), the pMGT vector permits the ex- 
pression of analytical quantities of proteins of up to 150 kD 
(A. H. Ahn, unpublished observations). 
While determining the syntrophin-binding site on dystro- 
phin in this present study, our collection of region-specific 
antibodies to dystrophin could no longer immunoprecipitate 
some of  the smaller expressed domains of dystrophin. Hence 
it became necessary to produce translated proteins that were 
tagged with a uniformly defined, unique antigen. A synthetic 
oligonucleotide encoding  the  octapeptide  FLAG  antigen 
(IBI/Kodak) was cloned into the NcoI-BamHI site of pMGT, 
giving rise to the vector pFHR. Both FLAG-dystrophin (see 
below) and FLAG-syntrophin fusion proteins (Fig. 1 b, lane 
9) were produced from pFHR, and were efficiently precipi- 
tated with the M2  anti-FLAG monoclonal antibody (IBI/ 
Kodak). 
Characterization  of  Dystrophin-Syntrophin 
Interaction by Immunoprecipitation 
The COOH terminus of dystrophin interacts with purified 
syntrophin immobilized onto a solid support (Cartaud et al., 
1993;  Suzuki  et  al.,  1994),  or  when  immuno-affinity 
purified from the receptor-rich membranes of the Torpedo 
electroplaque (Butler et al., 1992) or from several rat tissues 
(Kramarcy et al.,  1994).  To confirm and better understand 
this interaction with a  single isoform of syntrophin in the 
soluble phase, we translated various portions of the dystro- 
IT7~  TMV  5'UTR  I MI  MCS  I po,y(A) I L I 
GCGCGCTTAA  TACGACTCAC  TATAGGGATA  TTTTTACAAC  AATTACCAAC 
AACAACAAAC  AACAAACAAC  ATTACAATTA  CTATTTACAA  TTACAACCAT 
GGGTACCGAG  GACTAGTCTC  GAGGATCCCG  GGATCGATAA  GCTTCTGCAG 
AATTCTAGAT  CTTAATTAAT  TAATAAAAAA  AAAAAAAAAA  AAAAAAAAAA 
AAAAAATTTA  GGTCGACGCG  TGCGGCCGCG  CGC 
Figure 1. Expression  ofdystrophin and syntmphin  polypeptides. (a) 
schematic diagram of the expression  cassette used for in vitro tran- 
scription~translation and  the  nucleotide sequence (below; see 
methods): the T7 RNA polymerase late promoter (/7); the fl' re- 
gion ofTMV (TMV5'UTR); an ATG start codon in a Kozak  context 
(M); a multiple cloning site (MCS), including NcoI at the start 
ATG, Kpnl, SpeI, XhoI, BamHI, Sinai, ClaI, HindIII, PstI, EcoRI, 
XbaI, and BglII; a poly(A) region, including  a polyadenylation  sig- 
nal; and further restriction sites for linearization  of  the plasmid (L), 
including  SalI, MluI, and Nod were cloned into Bluescript  digested 
with BssHII. The arrows mark the beginning  of  transcription by the 
RNA polymerase and the NeoI site with the initiator ATG is under- 
lined.  (b)  SDS-PAGE and  autoradiography (see Materials and 
Methods) of a representative set of in vitro translated proteins 
within the vector pMGT (see Table I; BA1 is translated from the 
T7 promoter within Bluescript 11 SK+).  Molecular weight stan- 
dards (1), C2979 (2), 131571 (3),  Dlf/1A148 (4),  DIf/1A276 (5), 
C3356D148 (6),  TDR (7),  BA1 (8),  and F/3,S (9). 
plain  COOH  terminus  and  Bj-syntrophin  and  combined 
them in an immunoprecipitation assay (Fig. 2). A constant 
amount  of  in  vitro-translated  "C-labeled  ~,-syntrophin 
(~A1, the probe, hereafter referred to as "translated syntro- 
phin') was combined with a polypeptide containing amino 
acids  2979-3685  of dystrophin (C2979),  which  was  ex- 
pressed nonradioactively. The proteins were incubated to- 
gether and the complex immunoprecipitated with an antise- 
rum to the COOH terminus of dystrophin (dl 1) CKoenig  and 
Kunkel,  1990)  and  protein-G  Sepharose.  The  observed 
coimmunoprecipitation  between dystrophin polypeptide and 
translated syntrophin  persisted in 0 mM, 150 mM, and 1,000 
mM NaC1 wash conditions, and was not disrupted by either 
1% Triton X-100 or RIPA buffer (Fig. 2, lanes 1-5).  It ap- 
pears  that  the  recovery  of translated  syntrophin is  most 
efficient in no-salt conditions, but a separate control experi- 
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tide (C2979) with translated radiolabeled  syntrophin, using the 
anti-dystrophin  antibody  dll.  After  incubation  with  protein 
G-Sepharose,  the samples were washed three times in Tris buffer 
and 0.1% Tween-20 with 0 mM NaC1 (I), 150 mM NaC1 (2), 1,000 
mM NaCI (3), TBST with 1% Triton X-100 (4), or RIPA buffer 
(5). No translated syntrophin was precipitated in the absence of 
dystrophin polypeptide  (6),  or antiserum  (7),  or when a  non- 
specific antibody to the  NH2 terminus  of dystrophin,  1-2a (8) 
(Koenig and Kunkel, 1990) was used. 
ment showed that the greater translated syntrophin activity 
in the pellet is accounted for by the efficiency  with which the 
anti-dystrophin antibody precipitates dystrophin (data not 
shown).  In our controls for specificity, withholding either 
dystrophin or the anti-dystrophin antibody from the reaction 
failed to precipitate the translated syntrophin, and addition 
of an antibody against the amino terminus of dystrophin, 
which does not precipitate the COOH terminus alone, failed 
to precipitate the complex (Fig. 2, lanes 6-8). 
Translated Syntrophin Interacts with the Differentially 
Spliced Area of Dystrophin 
The structural requirements of  the dystrophin-syntrophin in- 
teraction were more precisely characterized by creating a set 
of nested dystrophin products of the COOH terminus of dys- 
trophin and DpT1 (Fig.  3 a).  Like sequences derived from 
full  sized  dystrophin,  Dp71,  which  contains  only  seven 
unique amino acids at its NH2 terminus,  also binds trans- 
lated syntrophin in a  similar assay.  COOH-terminal dele- 
tions of Dp71, up to 148 amino acids (DpT1A148), continued 
to bind translated syntrophin, while a protein with a deletion 
of  276 amino acids (Dp71A276)  failed to bind (Fig. 3 a, lane 
Figure 3. Localization of the syntrophin binding site to exon 74 of dystrophin. Anti-dystrophin antibody dl 1 (a) or anti-FLAG monoclonal 
antibody (b) coprecipitated dystrophin polypeptides with translated syntrophin. After incubation with protein G-Sepharose,  the pellets 
were washed three times, boiled in loading buffer, electrophoresed in SDS-PAGE, and translated syntrophin detected by autoradiography 
(see Materials and Methods). The upper portion of each figure is a schematic representation of  the polypeptides tested and their interpreta- 
tion ("+" for coprecipitation of translated syntrophin and "-" for no detected signal). The lower portion shows the autoradiographic data 
from the assay (see Materials and Methods). (a) A series of COOH-terminal dystrophin polypeptides (1 and 2) and a translated Dp71 poly- 
peptide (3) coprecipitate translated syntrophin. A 148-amino acid COOH-terminal deletion of Dp71 still binds translated syntrophin (4), 
but a larger deletion of  276 amino acids fails to bind (5). A polypeptide spanning the alternatively spliced region binds translated syntrophin 
(6), whereas an expressed polypeptide that represents a naturally occurring splice variant of Dp71 which is missing this region fails to 
bind (7). Control assays in which the dystrophin polypeptide (-dys) or the antibody (-Ab) were withheld are negative. (b) FLAG--dystrophin 
fusion polypeptides encoding exons 72-74 coprecipitate translated syntrophin (1), as do FLAG-fusion polypeptides representing exons 
73-74 (2) or exon 74 alone (3 and 4). FLAG-fusion polypeptides of only portions of exon 74 (5 and 6) failed to coprecipitate translated 
syntrophin. Control assays in which the dystrophin polypeptide (-dys) or the antibody (-Ab) were withheld are negative. 
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amino acids 3356-3537 of dystrophin (from the end of exon 
70 to the beginning of exon 75), also bound translated syn- 
trophin (Fig.  3 a, lane 6). 
Dystrophin amino acids 3356-3537 include those encoded 
on exons 71 through 74, which axe known to be alternatively 
spliced in skeletal muscle, brain, and heart (Feener et al., 
1989; Bies et ai.,  1992). The alternative splicing generates 
transcripts that are missing various in-frame combinations of 
these exons,  including  forms that lack this  entire region, 
amino acids 3409-3518 of dystrophin. We expressed a Dp71 
protein in which the 110 amino acids encoded by exons 71-74 
were internally deleted (Dp 71All0) and showed that it failed 
to bind syntrophin in our assay (Fig.  3 a, lane 7). 
A nested series of expression constructs were used to ex- 
press  progressively smaller  portions  of this  alternatively 
spliced region of dystrophin (Fig,  3 b). Since the available 
antibodies to dystrophin do not immunoprecipitate this re- 
gion  alone,  we  cloned amplified  eDNA  into  pFHR,  in- 
troducing amino-terminal fusions of the FLAG octapeptide 
with the proteins of interest. The FLAG-dystrophin fusion 
proteins also bound translated syntrophin when immunopre- 
cipitated with the anti-FLAG monoclonal antibody M2 (Fig. 
3 b). In each case, precipitation of translated syntrophin de- 
pended upon the inclusion of dystrophin fusion protein to 
the assay,  and the dystrophin-syntrophin complex did not 
precipitate in the absence of M2 antibody (Fig.  3 b, lanes 
"-dys" and "-Ab").  A  FLAG-dystrophin fusion protein in- 
cluding the amino acids encoded on exon 74 (F74-01)  was 
sufficient to bind translated syntrophin (Fig 3  b,  lane 4). 
FLAG-dystrophin fusion proteins of the first or second half 
of exon 74 (F74A and F74B) failed to coprecipitate trans- 
lated syntrophin in our assay (Fig.  3 b, lanes 5  and 6). 
As a further control of specificity, we performed the con- 
verse immunoprecipitation, in which a radiolabeled dystro- 
phin COOH terminus and an unlabeled syntrophin polypep- 
tide were combined and precipitated with an antibody to the 
translated syntrophin polypeptide. In this instance, we sub- 
cloned the eDNA encoding the last 335 amino acids of/31- 
syntrophin  into  the  FLAG  fusion  vector  (pFHR).  This 
FLAG-syntrophin fusion protein, F/3~S (Fig.  1 b, lane 9), 
together  with  the  anti-FLAG  monoclonal  antibody  M2, 
specifically coimmunoprecipitated the COOH terminus of 
dystrophin (Fig. 4 a, lane 1 ). 
DRP and 87K Polypeptides Also Bind 
Translated Syntrophin 
To examine whether the exon 74-encoded region on dystro- 
phin is functionally preserved in the two other dystrophin 
relatives,  human DRP  and the  Torpedo 87K postsynaptic 
protein, we tested translated DRP and 87K probes in a simi- 
lax assay.  A large COOH terminal portion of DRP and all 
of the 87K protein were produced as radiolabeled polypep- 
tides.  The FLAG-syntrophin fusion protein coprecipitates 
both  the  translated  DRP  and  87K proteins,  and  fails  to 
precipitate when the FLAG-syntrophin fusion protein or the 
anti-FLAG antibody axe omitted from the assay (Fig. 4 a). 
The converse experiment was also performed, in which 
the FLAG-antigen was switched to the other polypeptide. 
Based upon the localization of the syntrophin binding site on 
dystrophin, the exon 74 homologous regions of DRP and 
87K  were  expressed  as  FLAG-fusion proteins.  All  three 
FLAG-fusion proteins of dystrophin, DRP, and 87K immu- 
noprecipitate the translated full-length/3~-syntrophin probe, 
whereas their complexes do not precipitate in the absence of 
M2 antibody (Fig. 4 b). 
Figure 4. The syntrophin  bind- 
ing  site  is  functionally con- 
served among the three dys- 
trophin family members.  (a) 
The FLAG-syntrophin fusion 
protein  F/3~S was  incubated 
with radiolabeled  polypeptides 
of  the COOH terminus of dys- 
trophin (1), the COOH termi- 
nus of DRP (2), and the 87K 
protein  (3)  and  precipitated 
with  anti-FLAG monoclonal 
antibody. The control reactions 
in which all three dystrophin 
family members were used in 
the absence of F/31S (4) or in 
the  absence  of  anti-FLAG 
monoclonal antibody (5) are 
negative. (b) The interaction 
is preserved when the FLAG 
antigen has been switched to 
the other protein. Radiolabeled 
syntrophin (dark arrow) was incubated with FLAG fusions of the exon 74-encoded region of dystrophin (/) the FLAG-fusion protein (the 
lower band) incorporated the radiolabel poorly, and is not easily seen in this exposure), the FLAG fusion of the homologous region of 
DRP (2) and the FLAG fusion of the homologous region of 87K protein (3) and precipitated with anti-FLAG monoclonal antibody. The 
presence of the FLAG-fusion proteins (light arrows) were followed by the addition of a small amount of [14C]leucine  to their translation 
reactions (see Materials and Methods). Precipitation of syntrophin depended on the addition of the anti-FLAG monoclonal antibody (4). 
An assay-equivalent  of translat~l syntrophin is shown for comparison (5). (c) alignment of  the amino acid sequences of exon 74 of dystro- 
phin and their homologous region from DRP and the 87K protein. Gaps in the sequence were made to maintain the alignment. The con- 
sensus line (con) lists the identical residues of the alignment (single letter abbreviation) and conservative differences (*). 
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trophin binding motif, an alignment of the 53 amino acids 
homologous to exon 74 of dystrophin in DRP and the 87K 
protein was prepared  (Fig. 4  c).  Exon 74-encoded amino 
acids are represented in capital single-letter amino acid ab- 
breviations. (An additional 2-4 amino acids from either side 
of exon 74 were expressed from the constructs F74-01, FDR, 
and F87  and are described in Table  I.)  Only 24%  of the 
residues in the area shown are identical in all three proteins, 
and they are 45 % similar when conservative differences are 
considered. The homology is dispersed throughout the exon- 
encoded region, and the highly acidic residues in dystrophin 
and DRP are not always conserved in the 87K protein. 
Discussion 
The  58-kD  peripheral  intracellular  dystrophin-associated 
phosphoprotein called syntrophin is a biochemically hetero- 
geneous (Yamamoto et al.,  1993) family of three isoforms 
encoded on three distinct genes (Adams et al., 1993; Alan et 
al., 1994; Yang et al., 1994).  These proteins are expressed 
in a wide variety of  tissues, each in an overlapping and distinct 
pattern of expression. Furthermore, the immunohistochemi- 
cal  localization  of  ot-syntrophin  and  /~-syntrophin  has 
shown that they have a segregated subcellular distribution. 
Localization of ot-syntrophin  to the entire sarcolemma and 
/$2-syntrophin to the neuromuscular junction has led to the 
hypothesis that the syntrophins may in part account for the 
distinct localization and perhaps functioning of dystrophin 
and DRP (Peters et al.,  1994).  Immunoaffinlty isolation of 
syntrophin from a large range of  rat tissues shows that dystro- 
phin, Dp71, and DRP each copurify with the syntrophins, 
and the respective converse immuno-affinlty purifications 
show that dystrophin and DRP probably interact with syntro- 
phin independently of each other (Kramarcy et al.,  1994). 
The biochemical heterogeneity of both the dystrophins and 
the syntrophins isolated from tissues, however,  makes this 
interaction difficult to study in further detail. 
To reconstruct and test these proposed interactions indi- 
vidually, we have expressed these components from cDNA 
in vitro. A defined isoform of human syntrophin,/3rsyntro- 
phin (Ahn et al., 1994),  interacts with the COOH terminus 
of human dystrophin in an immunoprecipitation assay. The 
specificity of  the dystrophin-syntrophin  interaction was veri- 
fied in a number of conditions (Fig. 2). First, the interaction 
is stable in a wide variety of salt and detergent conditions. 
Second, syntrophin remains in the supernatant when dys- 
trophin COOH terminus is omitted from the precipitation. 
Third, the dystrophin-syntrophin  complex remains in the su- 
pernatant in the absence of antibody to the COOH terminus 
of dystrophin, and does not precipitate when a non-specific 
antibody is added.  Finally, in the converse precipitation, a 
FLAG-syntrophin fusion protein of the COOH terminal 37 
kD of/~-syntrophin can coprecipitate a translated, radio- 
labeled dystrophin fragment (Fig. 4 a). 
Since Dp71 differs from dystrophin by only seven amino 
acids at its NH2 terminus, we were not surprised to find 
that Dp71 also coprecipitates translated syntrophin (Fig. 3 a). 
This result is in agreement with an independent set of experi- 
ments, in which Dp71 immuno-affinity  purified from rat liver 
copurified with syntrophin (Kramarcy et al.,  1994). 
We have mapped a syntrophin binding site on dystrophin 
to exon 74, a region which is alternatively spliced in skeletal 
muscle, brain, and heart. In our assay, this region of dystro- 
phin  is  necessary  to  coprecipitate  translated  syntrophin, 
since the translated product of a splice variant which lacks 
this  region  does  not  coprecipitate  translated  syntrophin 
probe (Fig. 3 a, lane 7).  Since the translated polypeptide 
Dp71All0 represents a naturally occurring splice variant of 
dystrophin and Dp71, this polypeptide is more likely to fold 
correctly than an arbitrary deletion mutant. It is still possible 
that another region of dystrophin also interacts with syntro- 
phin,  but in our assay,  its interaction alone is not strong 
enough to coprecipitate translated syntrophin in the absence 
of exons 71-74.  Another possibility is that our polyclonal 
anti-dystrophin antibody (dl I) interferes with the binding ac- 
tivity of another COOH-terminal region of dystrophin. This 
other part of  dystrophin may play a regulatory or modulatory 
role in the interaction between dystrophin and one or more 
of the syntrophins. 
In  the  accompanying paper,  an  independent  series  of 
experiments by Suzuki and colleagues suggest that a-syn- 
trophin  and  /~-syntrophin  have  slightly different binding 
sites, but both reside substantially within exon 74. They also 
suggest that a further weak interaction exists between syntro- 
phin and the far COOH terminus of dystrophin (Suzuki et 
al.,  1995). 
The Exon 74-encoded Polypeptide Is 
Functionally Conserved 
The  syntrophin-binding site on dystrophin is functionally 
conserved in the dystrophin relatives DRP and 87K protein 
(Fig. 4, a and b). We have not ruled out the possibility that 
other regions of DRP and 87K also interact with syntrophin. 
The functional conservation of this domain is particularly 
revealing in that the 87K protein is so distantly related to 
dystrophin (Fig. 4 c). Whereas the syntrophin-binding do- 
mains of dystrophin and DRP contain many acidic residues, 
the 87K protein conserves only a few of these. The stability 
of the dystrophin-syntrophin interaction in high salt condi- 
tions also argues against the interaction being purely elec- 
trostatic in nature (Fig. 2). Rather, the conserved sequence 
is  dispersed throughout the exon-encoded region and in- 
cludes both charged and hydrophobic residues (Fig. 4  c). 
Pairwise comparison of the 87K protein to the homologous 
region of dystrophin shows that this particular region is no 
more conserved between the two proteins than the rest of the 
protein (Wagner et al.,  1993). 
The 53 amino acids encoded on exon 74 are predicted to 
be alpha-helical, bisected by at least one proline that is con- 
served in all three proteins. Expression constructs that divide 
exon 74 into these two smaller helical regions alone, how- 
ever, do not bind syntrophin (Fig. 3 b). This exon-encoded 
region may thus form a  helix-turn-helix domain which is 
necessary for the formation of a binding site to syntrophin. 
It is also possible that this relatively small region does not 
form any significant tertiary structure, and instead acts as a 
signal peptide for its association with syntrophin. This kind 
of interaction is observed between the src SH2 domain and 
six  residues  of a  high-affinity l 1-residue  phosphopeptide 
(PQ(pY)EEI),  whose crystal structure was  recently deter- 
mined (Waksman et al., 1993). The exon 74-encoded region 
is distinct from the amphipathic helical region identified by 
Wagner as a possible site of dystrophin interaction with the 
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cines and other hydrophobic residues are conserved in the 
consensus sequence, the repeated heptad motif characteris- 
tic of the leucine zipper is not strongly evident in the helical 
regions of this exon. 
The Dystrophin-Syntrophin  Interaction in the 
Membrane Cytoskeleton 
The exon 74-encoded region on dystrophin may help localize 
dystrophin and its relatives to the membrane cytoskeleton. 
On the other hand, it may be dystrophin and its relatives that 
direct the segregated distribution of the syntrophins. We have 
found that a recombinant COOH-terminal  37-kD fragment 
of syntrophin is sufficient to interact with translated dystro- 
phin and its homologues in our assay (Fig. 4 a).  Since the 
COOH termini of all three syntrophins are relatively well- 
conserved  compared  to  their  NH2  termini  (Ahnet  al., 
1994), their affinities for each of the dystrophins and dystro- 
phin relatives should be preserved. 
The specialized subcellular localization of the syntrophins 
and dystrophins may thus be determined by either quantita- 
tive differences in pairwise affinity or in other modifying fac- 
tors. One modifying factor that may address qualitative or 
quantitative differences in the dystrophin-syntrophin  inter- 
action  may  reside  in  the  phosphorylation  of syntrophin. 
Syntrophin  is phosphorylated  at both serine  and tyrosine 
residues  (Yamamoto  et  al.,  1993;  Wagner  and  Huganir, 
1994). In addition, dystrophin itself may be phosphorylated 
at a serine and/or threonine residue at a site distal to the exon 
74-encoded region (Milner et al.,  1993; Madhavan and Jar- 
rett,  1994). 
The role of the dystrophin-syntrophin interaction may be 
elucidated by the relationship of this complex to other com- 
ponents of the DGC and membrane cytoskeleton.  Results 
from other groups suggest that the molecular organization of 
dystrophin with other components of the DGC is compli- 
cated. An mdx mouse bearing a transgene of dystrophin with 
an internal deletion of exons 71-74 restores the DGC mem- 
bers to the sarcolemma, and restores many features of nor- 
real muscle histology (Rafael et al.,  1994). It is not known 
whether syntrophin functions normally at the membrane in 
this mouse. This result suggests one of two mutually compat- 
ible alternatives:  either syntrophin's association with other 
members of the complex is sufficient for localization and sta- 
bility or there is a separate site on dystrophin which forms 
a physiologically significant interaction with syntrophin in 
vivo which we do not observe in vitro. 
Are Both Dystrophin and Dp71 Alternatively Spliced? 
Exons  68,  71-74,  and  78  of dystrophin  are  alternatively 
spliced in skeletal muscle, cardiac muscle, brain, and vari- 
ous fetal tissues  (Feener et al.,  1989;  Bies et al.,  1992). 
These  studies  do  not  distinguish  between the  alternative 
splicing of the full-length dystrophin and the COOH-termi- 
hal transcript  Dp71,  which is present in all tissues except 
adult skeletal muscle. Since the binding site localization to 
this region suggests that the differential splicing of dystro- 
phin is of functional significance, this distinction is now par- 
ticularly relevant. Independent studies carded out in differ- 
ent organisms and tissues suggest that spliciforms of exon 74 
are present in both dystrophin and Dp71 (D. C. Gorecki, in 
preparation;  and J. S. Chamberlain,  manuscript in prepara- 
tion; A.  H. Ahn and L. M. Kunkel, unpublished observa- 
tions). Since these variably spliced forms are present in low 
proportion to the full-length transcript  (Bies et al.,  1992), 
this result implies that there is a small pool of dystrophin that 
does not associate directly with syntrophin.  Their relative 
scarcity, however, does not rule out the possibility that they 
play a  significant  role in some specialization  of the cyto- 
skeleton. 
The authors would like to thank E. M. McNally, H.  S. Selig, M. Bowe, 
E. Gussoni, I". J. Byers, A. Viel, S. Grossman, J. B. Cohen, and S. C. Hard- 
son for their advice and comments, and A. Suzuki, M. Yoshida,  E. Ozawa, 
K.  E  Campbell, J.  A.  Rafael, J.  S.  Chamberlain, D.  C.  Gorecki, S.  C. 
Froehner, and R. Sealock for sharing their results before publication. The 
Torpedo 87K eDNA was a kind gift ofJ. B. Cohen, and that of DRP2 cDNA 
by T. S. Khurana. The authors are deeply indebted to C. A. Feener, R. R. 
Bennett, and S. Bruno for their technical assistance. 
This  work  has  been  supported  by  National  Institutes  of  Health 
2T32GM07753  to A. H. Ahn, and National Institutes of Health program 
HD18658  to L. M. Kunkel. L. M. Kunkel is an Investigator of the Howard 
Hughes Medical Institute. 
Received for publication 23 August 1994 and in revised form 18 October 
1994. 
~¢~rence$ 
Adams, M. E., M. H. Butler, T.  M. Dwyer, M. F. Peters, A. A. Murnane, 
and  S.  C.  Preehner.  1993.  Two  forms of mouse  syntrophin,  a  58  kD 
dystrophin-associated  protein, differ in primary structure and tissue distribu- 
tion. Neuron.  11:531-540. 
Aim, A. H., M. Yoshida,  M.  D. S. Anderson, C. A. Feener, S. Selig,  Y. 
Hagiwara, E. Ozawa, and L. M. Kunkel. 1994. Cloning of human basic A 1, 
a distinct 59-kDa  dystrophin-associated  protein encoded on chromosome 
8q23-24.  Proc.  Natl.  Acad.  $ci.  USA. 91:4446--4450. 
Arahata, K., S. Ishiura, T. Ishiguro,  T. Tsukahara,  Y. Suhara, C. Eguchi, T. 
Ishihara,  I. Nonaka,  E. Ozawa,  and H.  Sugita.  1988. Immunostaining  of 
skeletal  and  cardiac  muscle  surface  membrane  with  antibody  against 
Ducbenne muscular dystrophy peptide.  Nature (Lond.).  333:861-863. 
Bies, R. D., S. F. Phelps, M. D. Cortez, R. Roberts, C. T. Caskey, andJ. S. 
Chamberlain.  1992. Human and murine dystrophin mRNA transcripts  are 
differentially  expressed during  skeletal muscle,  heart,  and brain develop- 
merit. Nucleic Acids Res. 20:1725-1731. 
Butler,  M. H., K. Douville, A. A. Murnane, N. R. Kramarcy,  J. B. Cohen, 
R. Seaiock, and S. C. Freehner. 1992. Association of the Mr 58,000 post- 
synaptic  protein of electric tissue  with  Torpedo  dystrophin and  the Mr 
87,000 postsynaptic  protein. J. Biol.  Chem.  267: 6213-6218. 
Byers, T. J., L. M. Kunkel, and S. C. Watkins.  1991. The subcellular distribu- 
tion of dystrophin  in mouse skeletal, cardiac, and smooth muscle. J.  Cell 
Biol.  115:411-421. 
Byers, T. J., H. G. W. Lidov, and L. M. Kunkel.  1993. An alternative dystro- 
phin transcript  specific to peripheral  nerve. Nature Genet.  4:77-81. 
Campbell, K. P., and S. D. Kahl. 1989. Association of dystrophin and an inte- 
grai membrane glycoprotein.  Nature (Lond.),  338:259-262. 
Carr, C., G. D. Fischbach, and J. B. Cohen. 1989. A novel 87,000-M, protein 
associated with acetylcholine  receptors in Torpedo electric organ and ver- 
tebrate skeletal muscle. J.  Cell Biol.  109:1753-1764. 
Cartaod, A., M. A. Ludosky, F. M. Tome, H. Collin, M. F. Stetzkowski, T. S. 
Khurana, L. M. Kunkel, M. Fardeau, J. P. Changeux, and J. Cartaud.  1992. 
Localization of  dystrophin and dystrophin-related protein at the electromotor 
synapse and neuromuscular junction in Torpedo marmoratu. Neuroscience. 
48:995-1003. 
Cartaud,  A., F. Stetzkowski-Marden,  and J. Cartaod.  1993. Identifcation  of 
dystrophin-binding  protein(s)  in membranes from Torpedo electrocyte  and 
rat muscle. J. Biol.  Chem.  268:13019-13022. 
Emery, A.  E.  H.  1993. Duchenne  muscular  dystrophy. Oxford University 
Press, New York. 392 pp. 
Ervasti,  J.  M.,  and K. P.  Campbell.  1991. Membrane organization  of the 
dystrophin-glycoprotein  complex. Cell.  66:1121-1131. 
Feener, C. A., M. Koenig, and L. M. Kunkel.  1989. Alternative  splicing of 
human dystrophin mRNA generates isoforms at the carboxy terminus.  Na- 
ture (Lond.).  338:509-511. 
Proehner, S. C., A. A. Mumane, M. Tobler, H. B. Peng, and R. Sealock. 
1987. A postsynaptic  M, 58,000  (58K) protein concentrated  at acetylcho- 
line receptor-rich  sites in Torpedo electroplaques and skeletal muscle. J. Cell 
Biol.  104:1633-1646. 
The Journal  of Cell Biology,  Volume 128, 1995  370 Gallie, D. R., D. E. Sleat,  J. W. Watts, P. C. Turner, and T. M. A. Wilson. 
1987. The Y-leader sequence of tobacco mosaic virus RNA enhances the ex- 
pression of foreign gene transcripts in vitro and in vivo. Nucleic Acids Res. 
15:3257-3273. 
Gallie,  D. R., D. E. Sleat, J. W. Watts, P. C. Turner, andT. M. A. Wilson. 
1988.  Mutational analysis of the tobacco mosaic virus Y-leader  for altered 
ability  to enhance translation. Nucleic Acids Res.  16:883-893. 
Khurana, T. S., S. C. Watkins, P. Chafey, J. Chelly, F. M. Tome, M. Fardeau, 
J. C. Kapian, and L. M. Kunkel. 1991.  Immunolocalization and develop- 
mental expression of dystrophin related protein in skeletal muscle. Neuro- 
mus. Dis.  1:185-194. 
Kocnig, M., and L. M. Kunkel. 1990. Detailed analysis of the repeat domain 
of dystrophin reveals four potential hinge segments that may confer flexibil- 
ity. J, Biol.  Chem.  265:4560--4566. 
Koenig, M., E. P. Hoffman, C. J. Bertelson, A. P. Monaco, C. Feener, and 
L. M, Kunkei. 1987. Complete cloning of the Duchenne muscular dystrophy 
(DMD) eDNA and preliminary genomic organization of the DMD gene in 
normal and affected  individuals. Cell.  50:509-517. 
Kozak, M. 1986. Point mutations define a sequence flanking the AUG initiator 
codon that modniates translation by eukaryotic ribosomes. Cell.  44:283- 
292. 
Kramarcy, N. R., A. Vidal, S. C. Froehner, and S. Sealock.  1994. Association 
of utrophin and multiple dystrophin short forms with the mammalian M, 
58,000  dystrophin-associated protein  (syntrophin). J.  Biol.  Chem.  269: 
2870-2876. 
Laemmli, U. K. 1970.  Cleavage of structural proteins during the assembly of 
the head of bacteriophage 1"4. Nature (Lond.).  227:680-685. 
Ledeffein, D.) Z. Levy, N. Augier, D. Mornet, G. Morris, O. Fuchs, D. Yaffe, 
and U. Nudel.  1992.  A 71-kilodalton  protein is the major product of the 
Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. 
Proc.  Natl. Acad.  Sci.  USA.  89:5346-5350. 
Lidov, H. G., T. J. Byers, S. C. Watkins, and L. M. Kunkel. 1990. Localiza- 
tion of dystrophin to postsynaptic regions of central nervous system cortical 
neurons. Nature (Lond.).  348:725-728. 
Lidov, H. G. W., T. J. Byers, and L. M. Kunkel. 1993.  The distribution of 
dystrophin in the murine central nervous system: an immunocytochemical 
study. Neuroscience.  54:167-187. 
Love, D. R., D. F. Hill, G. Dickson, N. K. Spurr, B. C. Byth, R. F. Marsden, 
F. S, Walsh, Y. H. Edwards, and K. E. Davies. 1989. An autosomal tran- 
script in skeletal  muscle with homology to dystrophin. Nature  (Lond.). 
339:55-58. 
Love, D. R., G. E. Morris, J. M. Ellis, U. Fairbrother, R. F. Marsden, J. F. 
Bloomfield,  Y. H. Edwards, C. P. Slater, D. J. parry, and K. E. Davies. 
1991. Tissue distribution of the dystrophin-related gene product and expres- 
sion in the mdx and dy mouse. Proc. Natl. Acad. Sci.  USA. 88:3243-3247. 
Madhavan, R., and H. W. Jarrett. 1994. Calmodulin-activated  phosphorylation 
of dystrophin. Biochemistry.  33:5797-5804. 
Matsumura, K., J. M. Ervasti, K. Ohlendieck, S. D. Kahl, and K. P. Campbell. 
1992.  Association of dystrophin-related protein with dystrophin-associated 
proteins in mdx mouse muscle. Nature (Lond.).  360:588-591. 
Milner, R. E., J, L. Busaan, C. F. B. Holmes, J. H. Wang, and M. Michalak. 
1993.  Phosphorylation of dystrophin: the carboxyl-terminal region of dys- 
trophin is a substrate for in vitro phosphoryiation by p34  c~2 protein kinase. 
J. Biol.  Chem.  268:21901-21905. 
Ohlendieck, K., J. M. Ervasti, K. Matsumura, S. D. Kahl, C. J. Leveille, and 
K. P. Campbell. 1991. Dystrophin-related protein is localized to neuromus- 
cuiar junctions of adult skeletal  muscle. Neuron. 7:499-508. 
Panayotatos, N., and R. D. Wells. 1979. Recognition and initiation site for four 
late promoters of phage I"7 is a 22-base pair DNA sequence. Nature (Lond.). 
280:35-39. 
Peters, M. F., N. R. Kramarcy, R. Sealock,  and S. C. Froehner.  1994.  /32- 
syntrophin: localization  at the neuromuscular junction in skeletal  muscle. 
Neuroreport.  5:1577-1580. 
Rafael, J. A., Y. Sunada, N. M. Cole, K. P. Campbell, J. A. Faulkner, and 
J. S. Chamberlain. 1994.  Prevention of dystrophic pathology in md.r mice 
by a truncated dystrophin isoform. Hum. Mol.  Genet.  1725-1733. 
Sambrook, J., E. F. Fritsch, andT. Maniatis. 1989. Molecular Cloding: A Lab- 
oratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 
New York. 
Suzuki, A., M. Yoshida, H. Yamamoto, and E. Ozawa. 1992. Glycoprotein- 
binding site of dystrophin is confined to the cysteine-rich  domain and the first 
half of the carboxy-terminal domain. FEBS (Fed. Eur. Biochem.  Soc.) Len. 
308:154-160. 
Suzuki, A., M. Yoshida, K. Hayashi, Y. Mizuno, Y. Hagiwara, and E. Ozawa. 
1994.  Molecular organization at the glycoprotein complex-binding site of 
dystrophin-Three dystrophin-associated proteins bind directly to the car- 
boxy-terminal portion of dystrophin. Fur. J. Biochem.  220:283-292. 
Suzuki, A., M. Yoshida, and E. Ozawa. 1995. Mammalian ~1- and ~l-syntro- 
phin bind to the alternative splice-prone region of the dystrophin COOH-Ter- 
minus. J.  Cell Biol.  128:373-381. 
Tinsley, J. M., D. J. Blake, A. Roche, U. Fairbrother, J. Riss, B. C. Byth, 
A. E. Knight, J. Kendrick-Jones, G. K. Suthers, D. R. Love et al., 1992. 
Primary structure of dystrophin-related protein.  Nature (Lond.).  360:591- 
593. 
Wagner, K. R., and R. L. Huganir. 1994. Tyrosine and serine phosphoryiation 
of dystrophin and the 58.kDa  protein in the postsynaptic membrane of 
Torpedo electric organ. J. Neurochem. 62:1947-1952. 
Wagner, K. R., J. B. Cohen, and R. L. Huganir. 1993. The 87K postsynaptic 
membrane protein from Torpedo is a protein-tyrosine kinase substrate ho- 
mologous to dystrophin. Neuron.  10:511-522. 
Waksman, G., S. E. Shoelson, N. Pant, D. Cowburn, and J. Kuriyan. 1993. 
Binding of a high affinity pbosphotyrosyl peptide to the src SH2 domain: 
crystal structures of the complexed and peptide-free forms. Cell.  72:779- 
790. 
Yamamnto, H., Y. Hagiwara, Y. Mizuno, M. Yoshida, and E. Ozawa. 1993. 
Heterogeneity of dystrophin-associated proteins. J. Biochem.  (Tokyo). 114: 
132-139. 
Yang, B., O. Ibraghimov-Beskrovnaya, C. R. Moomaw, C. A. Slaughter, and 
K. P. Campbell. 1994.  Heterogeneity of the 59-kDa dystrophin-associated 
protein revealed by eDNA cloning and expression. J.  Biol.  Chem.  269: 
6040-6044. 
Yoshida, M., and E. Ozawa.  1990.  Glycoprotein complex anchoring dystro- 
phin to sarcolemma. J. Biochem.  (Tokyo).  108:748-752. 
Ahn and Kunkel Syntrophin Binds a Spliced Exon of Dystrophin  371 